What is the appropriate evaluation and management for scleral redness with discomfort?

Scleral Redness with Discomfort: Evaluation and Management

Scleral redness with discomfort requires immediate differentiation between conjunctivitis (self-limited) and scleritis (vision-threatening), with scleritis demanding urgent ophthalmology referral and aggressive systemic therapy.

Critical First Step: Distinguish Scleritis from Conjunctivitis

The key distinction determines whether you're managing a benign condition versus a medical emergency 1:

Red Flags Requiring URGENT Ophthalmology Referral:

• Severe, deep, boring eye pain (worse than expected for simple redness)
• Vision loss or significant photophobia
• Pain with eye movement
• Scleral necrosis, nodules, or violaceous hue (not just superficial vessel injection)
• History of recent ocular surgery (especially pterygium, cataract) or trauma 2, 3
• Failure to respond to or worsening with topical corticosteroids (suggests infectious scleritis) 3

If Scleritis is Suspected or Confirmed

Immediate Actions:

1. Rule out infectious causes first - particularly if history of surgery, trauma, contact lens use, or immunosuppression 2, 3

   • Obtain cultures before starting treatment
   • Look for scleral abscesses, hypopyon, mucopurulent discharge
   • Infectious scleritis (5-10% of cases) mimics autoimmune disease and delays are catastrophic 3

2. Initiate systemic workup for autoimmune disease 4:

   • Rheumatoid arthritis (most common association)
   • Granulomatosis with polyangiitis (most common vasculitis cause)
   • Complete autoimmune panel including ANA, ANCA, RF

3. Start aggressive treatment 5, 4:

   • Corticosteroids remain the mainstay for non-infectious scleritis
   • Mild cases: NSAIDs or topical corticosteroids may suffice
   • Moderate-severe: Systemic corticosteroids required
   • Necrotizing scleritis: Immediate systemic immunosuppression + corticosteroid-sparing agents (methotrexate, rituximab, biologics)

Common Pitfall:

Never start immunosuppression without excluding infection - this is the most critical error that leads to devastating outcomes 2, 3.

If Conjunctivitis is More Likely

Based on the 2024 AAO Conjunctivitis Preferred Practice Pattern 6:

Clinical Objectives:

• Establish diagnosis and differentiate from other red eye causes
• Identify specific etiology
• Relieve discomfort while avoiding indiscriminate treatment

Key Management Principles:

Avoid indiscriminate topical antibiotics or corticosteroids 6:

• Viral conjunctivitis (most common) won't respond to antibiotics
• Mild bacterial conjunctivitis is self-limited
• No evidence supports superiority of any topical antibiotic

Specific Scenarios:

Allergic conjunctivitis:

• Seasonal/perennial: Antihistamines, mast cell stabilizers
• Vernal (severe): Topical corticosteroids necessary for acute exacerbations 6

Dry eye/blepharitis (most frequent causes of conjunctival inflammation):

• Treat underlying condition, not just inflammation 6

Hyperacute purulent discharge:

• Gonococcal conjunctivitis is vision-threatening - requires immediate systemic antibiotics 6

Associated Systemic Conditions to Screen For:

• Superior limbic keratoconjunctivitis → thyroid disorder
• Floppy eyelid syndrome → sleep apnea (order sleep study) 6

Practical Algorithm

1. Assess pain severity and character:

   • Mild irritation/grittiness → likely conjunctivitis
   • Severe, deep, boring pain → scleritis until proven otherwise

2. Check visual acuity:

   • Any vision loss → urgent referral 1

3. Examine scleral vessels:

   • Superficial, mobile vessels → conjunctivitis
   • Deep, immobile, violaceous → scleritis

4. Review history for risk factors:

   • Recent surgery/trauma + worsening symptoms → infectious scleritis 2, 3
   • Rheumatologic disease → non-infectious scleritis 4

5. If scleritis: Urgent ophthalmology referral same day

6. If conjunctivitis: Supportive care, avoid unnecessary antibiotics/steroids 6

The distinction between these conditions is critical because scleritis can lead to vision loss and requires systemic immunosuppression, while most conjunctivitis is self-limited and overtreating causes harm 6, 4.